|
Email:
|
jarmila.szilasiova@upjs.sk | |
|
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/jarmila.szilasiova | |
|
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
|
Department:
|
NLK
-
Department of Neurology
|
|
|
Office:
|
||
|
Phone:
|
640+ kl. 3787 | |
|
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
|
Department:
|
NLK
-
Department of Neurology
|
|
|
Office:
|
||
|
Phone:
|
640+ kl. 3787 | |
|
ORCID ID:
|
https://orcid.org/0000-0001-5971-8656 |
|
Overview of the responsibility for
the delivery, development and quality assurance of the study programme or its part
at the university in the current academic year
|
|
Study programme: General medicine - person responsible for the profile course, study field: General medicine, I.+II. degree
|
|
Study programme: Neurology - member of the commission for specialization study
|
|
Profile courses
|
|
Neurophysiology and neurogenetics - Neurology, III. degree
|
|
Neurology 2 - General medicine, I.+II. degree
|
|
Neurology - Neurology, III. degree
|
|
Overview of the responsibility for
the development and quality of the field of habilitation procedure and inaugural procedure
in the current academic year
|
|
Name of the field of habilitation procedure and inaugural procedure:
neurology - member of ROHIK, study field to which it is assigned: General medicine
|
|
Selected publications
|
|
Szilasiová J., Rosenberger J., Fedičová M., Mikula P., Urban P., Gdovinová Z., Vitková M., Hanes J., Stevens E. Neurofilament Light Chain Levels Are Associated with Disease Activity Determined by No Evident Disease Activity in Multiple Sclerosis Patients. In: European Neurology. - ISSN 0014-3022. - Roč. 84, č. 4 (2021), 271-279. - DOI 10.1159/000515806 PMID: 34034261 Q3, 2020 IF=1.71 Citations: 10 |
|
Berger T., Adamczyk-Sowa M., Csépány T., Fazekas F., Hojs Fabian T., Horáková D., Horvat Ledinek A., Illes Z., Kobelt G., Šega Jazbec S., - Klímová E., Leumtzer F., Rejdak K., Rozsa C., Sellner J., Selmaj K., Štourač P., Szilasiová J., Turčani P., Vachová M., Vaněčková M., Vécsei L., Havrdová E. Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease. In: Therapeutic Advances in Neurological Disorders. - ISSN 1756-2856. - Roč. 13, (2020), Art. No. 1756286420975223, s. [1-13]. - DOI 10.1177/1756286420975223 2020 IF=6.570; 2020 Q1 (Clinical Neurology) SCIE www. https://pubmed.ncbi.nlm.nih.gov/33335562/ Citations: 7 |
|
Szilasiová J., Mikula P., Rosenberger J., Fedičová M., Gdovinová Z., Urban P., Frigová L. Plasma neurofilament light chain levels are predictors of disease activity in multiple sclerosis as measured by four-domain NEDA status, including brain volume loss. In: Multiple Sclerosis Journal. - ISSN 1352-4585. - Roč. 27, č. 13 (2021), s. 2023-2030. DOI 10.1177/1352458521998039 IF (2021) = 5,85, Q1 http://pubmed.ncbi.nlm.nih.gov/33635154/ Citations: 9 |
|
Szilasiová J., Rosenberger J., Mikula P., Vitková M., Fedičová M., Gdovinová Z. Cognitive Event-Related Potentials-The P300 Wave Is a Prognostic Factor of Long-Term Disability Progression in Patients With Multiple Sclerosis. In: J Clin Neurophysiol. 2020 Oct 5. doi: 0.1097/WNP.0000000000000788. Online ahead of print.PMID: 33031128 https://pubmed.ncbi.nlm.nih.gov/33031128/ 2020 IF= 2.4, Q3 Citations: 4 |
Annual Plasma Neurofilament Dynamics Is a Sensitive Biomarker of Disease Activity in Patients with Multiple Sclerosis In: Medicina. - ISSN 1648-9144. - Roč. 59, č. 5 (2023), art. no. 865, s. 1-11. DOI:10.3390/medicina59050865 2023 IF= 2,4; 2023 Q1 Citations: 2 |
|
Selected projects
|
|
VEGA 1/0594/17. Behavioral and social factors, coping strategies and quality of life in patients with multiple sclerosis, 2017-2019, Lead researcher: Mgr. Pavol Mikula, Ph.D. Role: co-researcher |
|
APVV-15-0719 - LORICCOM: Longitudinal research of psychosocial innovations in the management of chronic disorders, 2016 - 2020. Lead researcher: Mgr. Iveta Rajničová Nagyová, Ph.D. Role: co-researcher |
|
VEGA MŠ SR č. 01/0540/20: Analysis of biomarkers of the origin and progression of CNS demyelinating disorders, 2020-2023. Lead researcher: assoc. prof. Mgr. Peter Urban, Ph.D. Role: co-researcher |
|
VEGA MŠ SR 1/0057/18: Analysis of neurofilament and miRNA in relationship to diagnostic, phenotype, activity, and responsiveness to multiple sclerosis therapy. 2018-2020. Lead researcher: Assoc. Prof. Jarmila Szilasiová, M.D., Ph.D. |
|
VEGA MŠ SR 1/0481/2023: Associations of blood molecular biomarkers with disease activity and brain atrophy in patients with multiple sclerosis. 2023- 2025. Lead researcher: prof. MUDr. Jarmila Szilasiová, M.D., PhD. |
|
International mobilities and visits
|
|
Univerzity Groningen, UMCG, Medical Faculty,, Groningen, Neederland, 27.1.2006 - 27.2.2006, Medical internship
|
|
Weill Medical College of Cornell University, Salzburg, Austria, 7.02.2003 - 13.02.2003, Lecture educational course
|
|
7th Course of the European School of Neuroimmunology, Oxford, Great Britain, 20.09.2007-23.09.2007, Lecture educational course
|
|
RS centrum, Všeobecní fakultní nemocnice v Praze, Neurologická klinika VFN, Praha, Prague, Czech republic, 1.09.2013- 13.9.2013, Medical internship
|
|
EACCME – European Accreditation Council for Continuing Medical Education: Enhancing
recovery in multiple sclerosis: from basic science to rehabilitation, Baveno, Italy, 26.11.2015-28.11.2015, Lecture educational course
|
|
Organisational activities
|
|
member - Academic Senate of Medical Faculty, Pavol Jozef Šafárik University in Košice, 2011-2015, 2019-2023
|
|
Chair of the Committaee - Section of Multiple Sclerosis of the Slovak Neurological Society, 2016-2020
|
